This inventor holds 7 USPTO granted patents. Top assignees: Virogenetics Corporation, Pasteur Merieux Serums Et Vaccins, University of Hawai'i. Active years: 1996-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lyon, FR (1998)
- Albany, NY (US) (1998)
- Lyons, FR (1996 - 2001)
Company Filing History:
5 out of 34 
1 out of 16 
1 out of 267 
Years Active: 1996-2001
Sure, I can help you with that! Let's proceed with the article about inventor Charles de Taisne.
Title: The Innovative Work of Charles de Taisne in Lyon, FR
Introduction:
Charles de Taisne, a distinguished inventor based in Lyons, France, has made significant contributions to the field of biotechnology with a total of 7 patents under his belt. His groundbreaking research and inventions have paved the way for advancements in vaccine development, particularly in the fight against malaria.
Latest Patents:
Among his latest patents is the "Malaria Recombinant Poxvirus Vaccine," a groundbreaking invention that involves a recombinant poxvirus, such as vaccinia virus, integrated with foreign DNA from Plasmodium Merozoite Surface Antigen 1. This innovative vaccine aims to induce a robust immunological response in host animals, offering promising prospects in malaria prevention.
Another notable invention is the "Malaria Recombinant Poxviruses," which features recombinant poxviruses containing foreign DNA from Plasmodium, encoding essential proteins like CSP, PfSSP2, LSA-1, and more. These vaccines have shown potential in eliciting immune responses and are designed with attenuated virulence for safer usage.
Career Highlights:
Charles de Taisne has garnered experience working with renowned companies in the biotechnology sector, including Virogenetics Corporation. His expertise and dedication to innovation have led to the successful development and patenting of novel vaccine technologies that hold promise for global health initiatives.
Collaborations:
Throughout his career, Charles de Taisne has collaborated with talented individuals in the field of biotechnology, such as Enzo Paoletti and Marion E Perkus. These partnerships have fostered creativity and knowledge exchange, contributing to the success of pioneering projects in vaccine research.
Conclusion:
In conclusion, Charles de Taisne's inventive spirit and commitment to advancing vaccination technologies have positioned him as a key figure in the fight against infectious diseases like malaria. His patents and collaborations reflect a legacy of innovation that continues to impact the field of biotechnology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile